Promacta

Active Ingredient(s): Eltrombopag
FDA Approved: * November 20, 2008
Pharm Company: * GLAXOSMITHKLINE
Category: Blood Clotting (Hemostasis)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Promacta Overview

Eltrombopag (rINN, codenamed SB-497115-GR) is a medication that has been developed for certain conditions that lead to thrombocytopenia (abnormally low platelet counts). It is a small molecule agonist of the c-mpl (TpoR) receptor, which is the physiological target of the hormone thrombopoietin. Eltrombopag was discovered as a result of research collaboration between GlaxoSmithKline and Ligand Pharmaceuticals. Designated an orphan drug in the United States and European Union, it is being manuf...

Read more Promacta Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Eltrombopag

Recent Promacta Forums: RSS Feed

Home

Is Promacta a prescription drug or available over the counter? ## Promacta (eltrombopag) is available by prescription-only. You can view details about this drugs "prescribing information" in the link below: More over, other drug details can be viewed here: Please post back if you have any other general questions or concerns about this drug.

Updated

Possible Dosages for this and Related Drugs:

Eltrombopag
  • For Suspension: Eq 25mg Acid/packet
  • Suspension: 25mg
  • Tablet: 12.5mg, 25mg, 50mg, 75mg, eq 100mg acid, eq 12.5mg acid, eq 25mg acid, eq 50mg acid, eq 75mg acid
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Promacta: (11 results)

Sorted by National Drug Code
  • 0007-4640 Promacta 25 mg Oral Tablet by Glaxosmithkline LLC
  • 0007-4641 Promacta 50 mg Oral Tablet by Glaxosmithkline LLC
  • 0007-4642 Promacta 75 mg Oral Tablet by Glaxosmithkline LLC
  • 0007-4643 Promacta 12.5 mg Oral Tablet by Glaxosmithkline LLC
  • 0007-4644 Promacta 100 mg Oral Tablet by Glaxosmithkline LLC
  • 0007-4646 Promacta 100 mg/1 Oral Tablet, Film Coated by Glaxosmithkline LLC
  • 0078-0684 Promacta 12.5 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
  • 0078-0685 Promacta 25 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
  • 0078-0686 Promacta 50 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
  • 0078-0687 Promacta 75 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
  • 0078-0972 Promacta 12.5 mg Oral Powder, for Suspension by Novartis Pharmaceuticals Corporation

Other drugs which contain Eltrombopag or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA